NCT07266350 2025-12-05A Non-interventional Registration Study of Monotherapy or Combination Regimens Based on Camrelizumab or Famitinib for the Treatment of Cervical CancerChongqing University Cancer HospitalNot yet recruiting1,300 enrolled